T. Denny Sanford, Malin Burnham, Jeanne Herberger, Gary Herberger and Conrad Prebys celebrate the annual Sanford-Burnham gala.
Last weekend, flappers and gangsters arrived in vintage cars to dance the night away at Sanford-Burnham’s gala—Speakeasy: Hidden in Plain Sight. The gala raised $2.2 million to support biomedical research at Sanford-Burnham.
This year’s gala was held at the Estancia La Jolla Hotel & Spa, where the ballroom was transformed into a Prohibition-era dance hall. Malin Burnham, T. Denny Sanford, and Conrad Prebys were honorary chairs. Life Technologies was the presenting sponsor, thanks to CEO Greg Lucier, Chairman of the Sanford-Burnham Board of Trustees.
Hibernating Herpes Viruses
Thursday, October 14th, 2010 Herpes viruses are good at hiding. They infect human cells and lay dormant there until replication is activated by stress or some other environmental factor. One type, Kaposi’s sarcoma-associated herpesvirus (KSHV), is one of only a few viruses known to cause cancer.
In a study that appeared online September 17 in the journal EMBO Reports, Sanford-Burnham’s Dr. Tariq Rana and colleagues found that KSHV stays quiet by expressing certain microRNAs (miRNAs), small strands of genetic material that interfere with protein production.
“KSHV dormancy is believed to be essential for tumor formation, yet some forms of cancers caused by the virus have also been linked to viral reactivation,” explains Dr. Rana, professor and director of Sanford-Burnham’s RNA Biology Program. “This study helps us better understand the KSHV life cycle, thus providing new insight into how the virus causes cancer in some populations.”
(more…)
In a study that appeared online September 17 in the journal EMBO Reports, Sanford-Burnham’s Dr. Tariq Rana and colleagues found that KSHV stays quiet by expressing certain microRNAs (miRNAs), small strands of genetic material that interfere with protein production.
“KSHV dormancy is believed to be essential for tumor formation, yet some forms of cancers caused by the virus have also been linked to viral reactivation,” explains Dr. Rana, professor and director of Sanford-Burnham’s RNA Biology Program. “This study helps us better understand the KSHV life cycle, thus providing new insight into how the virus causes cancer in some populations.”
(more…)
Drug Design in 3D
Tuesday, October 5th, 20103D representation of a protein, a known cancer drug target. The protein's pocket (center, in pink) holds matching fragments identified by MEDIT software. The software will then further analyze these fragments to build new anti-cancer compounds that bind the protein
To boost the Prebys Center’s drug discovery efforts, scientists in Dr. Nicholas Cosford’s laboratory, part of Sanford-Burnham Cancer Center’s Apoptosis and Cell Death Program, are putting on their 3D glasses. They recently teamed up with French company MEDIT SA to use and enhance a new software platform built around a computer program called MED-SuMo. This platform breaks down 3D images of known protein structures to find chemical fragments that might bind and inhibit Protein X (or other interesting proteins) in real life.
(more…)
Running for Research
Friday, October 1st, 2010Judy Wade is all smiles, arriving at Sanford-Burnham’s La Jolla campus sporting shorts and a T-shirt that reads, “Will Run for Coffee.” She really means it. Though she never ran before joining Team Sanford-Burnham, it now seems that running is part of Wade’s identity.
The annual run with Team Sanford-Burnham allows participants to run side-by-side with the very scientists whose work they are supporting. “When they formed this team about five years ago, I thought it would be a good idea to do something new for a good cause,” Wade recalls. “I wasn’t a runner. I didn’t even like it, but now I love it.”
(more…)
Where Structure Meets Function
Thursday, September 30th, 2010 The human genome project taught us a lot about the number and sequences of our genes, but not a whole lot about what they do. In the years since, scientists have been using that genomic information to examine the structures of proteins, the molecules that carry out our genes’ instructions (see DNA 101). Structural information is being used to answer biological questions about protein function – how they facilitate chemical reactions, carry molecular signals in and out of cells and control cellular movements. There’s a growing need to understand how multiple proteins work together to accomplish all that and more.
As part of their Protein Structure Initiative (PSI), the National Institute of General Medical SciencesNational Institutes of Health has awarded a five-year, $6.8 million grant to a team led by Sanford-Burnham’s Dr. Robert Liddington and Stanford University’s Dr. W. James Nelson. PSI was formed in 1999 to help researchers establish the structure of more proteins, faster. Now in its third phase, called PSI:Biology, PSI structure determination centers are partnering with scientists like Dr. Liddington and Dr. Nelson to address important biological questions linking a protein’s structure and its function. (NIGMS) at the
(more…)
As part of their Protein Structure Initiative (PSI), the National Institute of General Medical SciencesNational Institutes of Health has awarded a five-year, $6.8 million grant to a team led by Sanford-Burnham’s Dr. Robert Liddington and Stanford University’s Dr. W. James Nelson. PSI was formed in 1999 to help researchers establish the structure of more proteins, faster. Now in its third phase, called PSI:Biology, PSI structure determination centers are partnering with scientists like Dr. Liddington and Dr. Nelson to address important biological questions linking a protein’s structure and its function. (NIGMS) at the
(more…)
Heart Team Gets Pumped Up
Tuesday, September 28th, 2010A collaborative team led by Dr. Gabriel Haddad at the University of California, San Diego (UCSD), which includes Sanford-Burnham’s Dr. Rolf Bodmer, Dr. Pilar Ruiz-Lozano, Dr. Karen Ocorr and Dr. Giovanni Paternostro, was awarded a $10 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health. The team will research the molecular response to low oxygen levels – a condition known as hypoxia – in heart, lung and brain cells.
“This funding will allow us to develop powerful predictions of how the human heart and other organs can be protected from hypoxia-inflicted injury by studying both fruit flies, which are very tolerant to low oxygen, and mice, which are less tolerant,” explains Dr. Bodmer, professor and director of Sanford-Burnham’s Development and Aging Program.
According to Dr. Paternostro, adjunct assistant professor, ”This grant will allow us to continue our work on the systems biology and metabolomics of hypoxia, an ongoing collaboration with Dr. Haddad and with the other scientists participating in the funded project.”
(more…)
Mitochondria Lovers Unite!
Friday, September 24th, 2010Squamous carcinoma cells, a type of skin cancer, with the nucleus in blue and mitochondria indicated in red. (Image provided by Dr. Eric Lau, Ronai laboratory)
While chatting at a retreat last spring, a few researchers decided they wanted to maintain the small community feeling the Institute is known for, even as we continue to expand. And so the Institute’s postdoctoral association, the Sanford-Burnham Science Network, initiated an effort to promote informal research interest groups—small clubs of scientists studying any number of different systems or diseases, but united by a common interest. Shortly after tossing around the idea, they held the first meeting of the first club, now called the Sanford-Burnham Mitochondria Research Interest Group (MRIG). (You might remember mitochondria from ninth grade biology – the organelles often referred to as the “powerhouse” because they generate the energy that helps cells survive and function properly.)
“Mitochondria are a growing area of interest at the Institute, more recently for myself and others, and sometimes the right techniques or protocols and reagents can be hard to find. Troubleshooting on your own can be even more frustrating,” explains Dr. Eric Lau, MRIG co-founder and postdoctoral researcher in Dr. Ze’ev Ronai’s laboratory. “So this group calls together all mitochondrial enthusiasts to meet regularly to share their own research stories, their successes, failures, frustrations…..in order to build a stronger mitochondrial research subcommunity here.”
(more…)
Race for Discovery: a Piece of Sanford-Burnham History
Thursday, September 23rd, 2010Ewing's sarcoma cells, a type of bone cancer that often metastasizes to the lungs and other bones. (Image courtesy of Wikimedia Commons)
At the same time Dr. Frisch was trying to publish his discovery of anoikis, a laboratory across the street at The Scripps Research Institute was about to issue the same finding. A recent article in The Scientist describes how the two labs simultaneously – but independently – discovered anoikis in 1993, and the separate paths they took to publishing that data.
(more…)
Sanford-Burnham Robots on TV
Thursday, September 16th, 2010 The hard-working robots and scientists in Sanford-Burnham’s Conrad Prebys Center for Chemical Genomics (Prebys Center) were profiled in three local news spots in the past week: Fox 35 Orlando, ABC 6 Orlando and NBC 7 San Diego (in collaboration with Voice of San Diego).
(more…)
(more…)
The Power of Basic Research
Wednesday, September 15th, 2010
Editor’s Note: A few months ago, we told you about a study in which a team of Sanford-Burnham scientists led by Dr. Yu Yamaguchi created a mouse model for a rare bone disease called multiple hereditary exostoses (MHE). Over the years, Dr. Yamaguchi has become friends with Sarah Ziegler, a woman whose son has had more than 100 MHE bone tumors and has suffered through 15 surgeries. Sarah co-founded The MHE Research Foundation to advocate for patients and research. Below is a letter she wrote to Dr. Yamaguchi, describing what his research has meant to her and her family.
Dear Dr. Yamaguchi,
Thank you for becoming my champion! You are the world leader in the effort to discover a cure for Multiple Hereditary Exostoses (MHE).
I clearly remember when I first started to read about your research. Even though you were not studying MHE at the time, I knew you were the one person in the world who could research this disease, with its myriad of effects, as a whole, rather than focusing on just one small aspect of it.
0 comments:
Post a Comment